Your First Week on a GLP-1 Drug: What to Expect and What Is Normal
The first week on a GLP-1 drug often surprises new patients — not because of dramatic effects, but because of the absence of them. Understanding why the experience is typically underwhelming in week one makes the following weeks easier to navigate.
This article awaits medical-reviewer signoff.
The starter dose: designed for tolerance, not effect
GLP-1 drugs use a titration protocol so the body adapts gradually. Initial doses are sub-therapeutic:
| Drug | Starter dose | Note |
|---|---|---|
| Semaglutide (Ozempic, Wegovy) | 0.25 mg weekly | 4-week ramp; not a therapeutic dose |
| Tirzepatide (Mounjaro, Zepbound) | 2.5 mg weekly | 4-week ramp; not the therapeutic starting dose |
| Liraglutide (Saxenda) | 0.6 mg daily | Week 1 ramp; therapeutic doses start at 1.2 mg |
The 0.25 mg semaglutide starter is approximately one-tenth of the maximum Wegovy dose. At this level, GLP-1 receptor occupancy is modest, appetite-suppression signalling is minimal, and GI side effects are typically mild.
Most patients describe the first week as uneventful. Weight loss in week one is essentially zero — the drug is not active enough to produce significant metabolic effect yet.
What the typical first week looks like
Day 1 (injection day): Minimal immediate effects. GLP-1 drugs are long-acting; there is no rapid onset. The injection site may have brief mild discomfort.
Hours 12–24 post-injection: When early GI symptoms most commonly appear. At the starter dose this is usually mild: possible mild nausea, bloating, or loose stool. Many patients notice nothing.
Days 2–4: Any first-injection GI symptoms have usually resolved. The drug is building concentration but sub-therapeutically. Some patients notice very mild appetite reduction; most do not.
Days 5–7: Body adapting. Energy may feel slightly lower in some patients as caloric intake patterns begin to shift. Most patients feel essentially normal.
What changes at dose escalation
The experience shifts at the first dose step up (typically week 5, moving from 0.25 mg to 0.5 mg for semaglutide). Each new step repeats a version of the first-week pattern but with more intensity:
- More noticeable appetite suppression
- More pronounced GI side effects (nausea, loose stool) in the 24–48 hours after the new dose
- These settle within 1–2 weeks as the body adapts to the new level
Peak side effect burden for most patients is at the first genuinely therapeutic dose (0.5 mg or 1 mg for semaglutide) and at higher escalation steps.
When to contact your prescriber before the scheduled check-in
Mild nausea, loose stool, reduced appetite, and fatigue in the 24–48 hours after injection are expected. The following warrant contact:
- Severe persistent abdominal pain (not mild nausea — severe pain that does not resolve) → possible pancreatitis
- Severe vomiting preventing any hydration → may need antiemetics or dose adjustment
- Injection site reaction not resolving: hardness, significant redness, swelling beyond a small bruise
- Significant palpitations not typical for you
Injection technique basics
For first-time self-injectors:
- All current GLP-1 pens use small-gauge needles (30–32 gauge, 4–8 mm) — typically not painful
- Sites: subcutaneous fat in abdomen, thigh, or upper arm — rotate injection sites
- Pre-filled autoinjector pens (Wegovy, Zepbound KwikPen): review technique with pharmacist at first fill
- Zepbound vials: require separate syringe; technique demonstration matters
Editorial note: This article awaits medical-reviewer signoff. First-week experiences vary. Discuss your specific experience with your prescriber.
Frequently asked questions
Why don't I feel any different in the first week on Ozempic or Wegovy?
The first dose of semaglutide is 0.25 mg — a sub-therapeutic starter dose designed to let the body adapt, not to produce appetite suppression. Significant appetite change typically becomes noticeable after escalation to 0.5 mg at week 5, and more pronounced through the 1 mg and 1.7 mg steps. Feeling nothing in week one is normal and expected. This page awaits medical reviewer signoff.
When do GLP-1 side effects start?
Side effects most commonly appear 12–24 hours after each injection, corresponding to peak drug concentration. They are typically mildest at the starter dose and intensify with each dose step up. Most side effects (nausea, loose stool, fatigue) are self-limiting — settling within 48–72 hours as the body adapts to the new dose.
Is it normal to feel nothing after the first injection?
Yes. Starter doses are calibrated to minimise side effects at the cost of minimal therapeutic effect. Most patients report little to no appetite change after the first injection. The first week is about tolerating the drug, not experiencing its full effect.
What should I eat in the first week?
No specific dietary restrictions are required by the labels in the first week. Practical guidance: smaller meals and avoiding very high-fat or very rich meals can reduce GI symptoms. Maintaining adequate hydration and protein intake matters even at the starter dose. Discuss specific dietary recommendations with your prescriber or a registered dietitian.